https://clinicaltrials.gov/study/NCT06815575
I am ready to begin.
@RaceOncology
How much information can be shared about the dose escalations at this stage?
Are the 5 dose escalations all Q3W, or are there opportunities for multiple day dosing? D2Q3W or D3Q3W?
RAC-010: First in-human CPACS Phase 1a/b clinical trial in combination with Doxorubicin
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.015(1.24%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.23 | $1.24 | $1.18 | $129.9K | 107.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 912 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4775 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| RAC (ASX) Chart |